Couldn’t make it to EAN 2020? Here’s what you missed
Covering a wide range of areas from the preclinical detection of diseases to neuroprotective disease-modifying treatments, fascinating expert-led sessions included:
- The important aspects of future neurology such as preventing disability and how to tackle neurodegenerative diseases in a fascinating plenary symposium
- How digital technology is transforming multiple sclerosis and how tailoring treatments can improve the risk/benefit profile of natalizumab
- An exciting controversy session on whether no evidence of disease activity (NEDA) is relevant in making therapeutic decisions in multiple sclerosis
This year’s EAN congress was packed with many more sessions sharing the latest news in the three fundamental challenges in neurological diseases - prediction, prevention and repair. If you want to see more click here to view the full scientific programme from EAN 2020.
Improving established MS therapies
How can long-term understanding of established therapies for multiple sclerosis (MS) be harnessed to improve the patient experience? Watch clips from this virtual satellite symposium.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
